Fraser AG, Rosalki SB, Gamble GG, Pounder RE. Inter-individual and intraindividual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal. Br J Clin Pharmacol 1995; 40:387- 392.

Fraser AG, Ali MR, McCullough S, Haystead A. Diagnostic tests for Helicobacter pylori - can they help select patients for endoscopy? NZ Med Journal 1996; 109: 95-8.

Fraser AG, Scragg R, Metcalf P, McCullough S, Yeates NJ. Prevalence of Helicobacter pylori in different ethnic groups in New Zealand children and adults.
Aust NZ J Med 1996; 26:646-51 (with editorial).

Fraser AG, Moore L, Berry S, Arroll B. Eradication treatment for Helicobacter pylori in general practice. NZ Med Journal 1996; 109: 422-4.

Schmid J, Fraser AG, Hollis B, O'Toole P. Ethnic tropism of DNA fingerprints of
Helicobacter pylori. Infection and Immunity 1997; 65: 3708-12.

Fraser AG, Peng S-L, Jass JR. Intestinal metaplasia subtypes and Helicobacter
pylori infection - a comparison of ethnic groups in New Zealand. J Gastro Hepatol 1998; 13: 560-565.

Fraser AG, Schreuder V, Chua L, Moore L. Follow-up after successful eradication of H.pylori - symptoms and re-infection. J Gastro Hepatol 1998; 13:
555-59.

Fraser AG, Moore L, Hackett M, Hollis B. H.pylori treatment and antibiotic
susceptibility: results of a five-year audit. Aust NZ J Med 1999; 29: 512-517.

Fraser AG, Morton RP, Gillebrand J. Presumed laryngo-pharyngeal reflux;
investigate or treat. J Otolaryngology 2000; 114: 441-47.

Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the
treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-
489.

Fraser AG, Morton D, McGovern D, Travis S, Jewell DP. The efficacy of
methotrexate for maintaining remission in inflammatory bowel disease. Aliment
Pharmacol Therap 2002; 16: 693-697.

Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy
after treatment of inflammatory bowel disease with azathioprine. Aliment
Pharmacol Therap 2002; 16: 1225-1232.

Fraser AG, Warren BF, Chandrapala R, Jewell DP. Microscopic colitis: a clinical
and pathological review. Scand J Gastroenterol 2002; 11: 1241-45.

Fraser AG. Helicobacter pylori: a historical perspective 1983-2003. NZ Med
Journal 2004; 117: 1194.

Fraser AG, Kandiel A, Korelitz BI, Brensinger C, Lewis JD. Increased risk of
lymphoma among inflammatory bowel disease patients treated with azathioprine
and 6-mercaptopurine. Gut 2005; 54, 1121-1125.

Leung E, Hong J, Fraser AG, Merriman TR, Vishnu P, Abbott WGH, Krissansen
GW. Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand
Crohn's disease patients. Immunology and Cell Biology 2005; 83: 498-503.